STOCK TITAN
  1. Home
  2. Sec-filings
  3. ATRC
  4. [Form 4] AtriCure, Inc. Insider Trading Activity

AtriCure, Inc. (ATRC) insider sells 6,182 shares at $38.80

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

AtriCure, Inc. reported that Chief Marketing & Strategy Officer Justin J. Noznesky sold 6,182 shares of common stock on July 29, 2026. The shares were sold at a weighted average price of $38.80 per share, in multiple trades ranging from $38.62 to $39.28. Following this transaction, Noznesky directly holds 100,219 shares of AtriCure common stock.

Positive

  • None.

Negative

  • None.
Insider Noznesky Justin J
Role Chief Mktg & Strategy Officer
Sold 6,182 shs ($240K)
Type Security Shares Price Value
Sale Common Stock F1 6,182 $38.80 $240K
Holdings After Transaction: Common Stock — 100,219 shares (Direct)
Footnotes (1)
  1. F1. This transaction was executed in multiple trades at prices ranging from $38.62 to $39.28 per share. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Shares Sold 6,182 shares Common stock sold by Justin J. Noznesky on July 29, 2026
Weighted Average Sale Price $38.80 per share Weighted average price for the 6,182 shares sold
Sale Price Range Low $38.62 per share Lowest price among multiple trades in the reported sale
Sale Price Range High $39.28 per share Highest price among multiple trades in the reported sale
Shares Held After Transaction 100,219 shares Directly held AtriCure common stock by Noznesky after the sale
Transaction Date July 29, 2026 Date of the insider sale of 6,182 shares
weighted average sales price financial
"The price reported above reflects the weighted average sales price."
open market or private transaction financial
"Transaction code S: Sale in open market or private transaction."
directly holds financial
"Following this transaction, Noznesky directly holds 100,219 shares of common stock."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What insider transaction did AtriCure, Inc. (ATRC) disclose for Justin J. Noznesky?
AtriCure, Inc. reported that Justin J. Noznesky sold 6,182 shares of common stock. The sale occurred on July 29, 2026, at a weighted average price of $38.80 per share, through multiple trades within a price range of $38.62 to $39.28.

At what prices were Justin J. Noznesky’s ATRC shares sold?
Justin J. Noznesky’s 6,182 AtriCure shares were sold at a weighted average price of $38.80. The transaction was executed in multiple trades, with individual sale prices ranging from $38.62 to $39.28 per share, according to the company’s disclosure.

How many AtriCure (ATRC) shares does Justin J. Noznesky hold after the sale?
After selling 6,182 shares, Justin J. Noznesky directly holds 100,219 shares of AtriCure common stock. This post-transaction holding reflects his remaining direct ownership position as reported in the company’s insider trading disclosure.

What role does Justin J. Noznesky hold at AtriCure, Inc. (ATRC)?
Justin J. Noznesky serves as AtriCure’s Chief Marketing & Strategy Officer. His recent reported activity involved selling 6,182 shares of AtriCure common stock at a weighted average price of $38.80 per share on July 29, 2026.

Was Justin J. Noznesky’s ATRC stock sale executed in a single trade?
No. The 6,182-share sale by Justin J. Noznesky was executed in multiple trades. AtriCure reports that these trades occurred at prices ranging from $38.62 to $39.28 per share, with a reported weighted average sales price of $38.80.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Noznesky Justin J
(Last)(First)(Middle)
7555 INNOVATION WAY
(Street)
MASON OHIO 45040-9695
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
AtriCure, Inc. [ ATRC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Mktg & Strategy Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/29/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/29/2026S6,182D$38.8(1)100,219D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. This transaction was executed in multiple trades at prices ranging from $38.62 to $39.28 per share. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Remarks:
/s/ Justin J. Noznesky07/30/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR